UK MHRA First-Half New Drug Approvals Show Overwhelming Use Of EU Reliance Procedures

 
• By Ian Schofield

The UK regulator approved 16 medicines containing a new active substance in the first half of this year, while the European Commission issued marketing authorizations for 20 NAS-containing drugs.

Approved stamp on application form or business agreement document
The MHRA uses reliance procedures in its new drug approvals • Source: Shutterstock

More from Europe

More from EU CHMP